Genix Pharmaceuticals Corporation (GENPF)
OTCMKTS
· Delayed Price · Currency is USD
0.0400
+0.0140 (53.85%)
At close: Jun 17, 2024
Genix Pharmaceuticals Statistics
Total Valuation
GENPF has a market cap or net worth of 1.28 million. The enterprise value is 1.93 million.
Market Cap | 1.28M |
Enterprise Value | 1.93M |
Important Dates
The next estimated earnings date is Thursday, June 26, 2025.
Earnings Date | Jun 26, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 59.22M |
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 47.83M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 465.22 |
PB Ratio | -1.43 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -23.02 |
EV / Sales | n/a |
EV / EBITDA | 13.97 |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.04
Current Ratio | 0.04 |
Quick Ratio | 0.01 |
Debt / Equity | n/a |
Debt / EBITDA | 4.73 |
Debt / FCF | n/a |
Interest Coverage | -2.61 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -146.07% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 27.45% |
Revenue Per Employee | 1 |
Profits Per Employee | -21 |
Employee Count | 4,000 |
Asset Turnover | 0.03 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.95% in the last 52 weeks. The beta is 0.35, so GENPF's price volatility has been lower than the market average.
Beta (5Y) | 0.35 |
52-Week Price Change | +6.95% |
50-Day Moving Average | 0.11 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 46.49 |
Average Volume (20 Days) | 11,817 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.24 |
Income Statement
In the last 12 months, GENPF had revenue of 2,750 and -83,874 in losses. Loss per share was -0.00.
Revenue | 2,750 |
Gross Profit | -124,888 |
Operating Income | -244,787 |
Pretax Income | -83,874 |
Net Income | -83,874 |
EBITDA | 132,664 |
EBIT | -244,787 |
Loss Per Share | -0.00 |
Balance Sheet
The company has 2,199 in cash and 627,588 in debt, giving a net cash position of -625,390.
Cash & Cash Equivalents | 2,199 |
Total Debt | 627,588 |
Net Cash | -625,390 |
Net Cash Per Share | n/a |
Equity (Book Value) | -891,622 |
Book Value Per Share | -0.02 |
Working Capital | -896,108 |
Cash Flow
Operating Cash Flow | -143,630 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | -8,901.35% |
Pretax Margin | -3,049.96% |
Profit Margin | n/a |
EBITDA Margin | 4,824.27% |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
GENPF does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -6.56% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
GENPF has an Altman Z-Score of -351.81. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -351.81 |
Piotroski F-Score | n/a |